Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-07

Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of a treatment for grass and olive pollen allergy is currently recruiting, targeting allergic rhinitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Inmunotek S.L. | Conditions: Rhinitis, Allergic, Rhinoconjunctivitis | Phase 3 | Status: RECRUITING